Cancer Drugs Current Events | Cancer Drugs News | 5
|
| Page
5 of
135 |
2691 Results |
|
|
|
Sort By:
Page Views | Date |
Key to lung cancer chemo resistance revealed
Scientists at Johns Hopkins have discovered how taking the brakes off a "detox" gene causes chemotherapy resistance in a common form of lung cancer. view more (2006-10-11)
Regular use of selective COX-2 inhibitors decreases risk of breast cancer
Regular use of selective COX-2 inhibitors significantly reduces the risk of breast cancer. view more (2006-01-30)
Researchers identify four new targets for breast cancer
Four suspects often found at the scene of the crime in cancer are guilty of the initiation and progression of breast cancer in mice that are resistant to the disease, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the June edition of Cancer Cell. view more (2009-06-11)
UC Davis researchers identify a protein that may help breast cancer spread, beat cancer drugs
New research from UC Davis Cancer Center shows that a protein called Muc4 may be the essential ingredient that allows breast cancer to spread to other organs and resist therapeutic treatment. view more (2009-04-02)
Mouse tests predict drug response in relapsing pancreatic cancer patients
By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately "test drive" chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey. view more (2006-10-12)
UT Southwestern researchers find marker for severity in adult brain cancer
Researchers at UT Southwestern Medical Center have identified a new biological indicator that may help identify which brain-cancer patients have the most aggressive forms of the disease. view more (2009-04-01)
Is there any association between COX2 and colon cancer?
Non-steroidal anti-inflammatory drugs (NSAIDs), which are known to reduce the risk of colon cancer, act directly on cyclooxygenase-2 (COX2) and reduce its activity. view more (2009-05-22)
New research provides hope for childhood cancer sufferers
Scientists investigating drug therapies for children with Acute Lymphoblastic Leukaemia (ALL) have presented new data demonstrating for the very first time that a small molecule called ABT-737 can increase the effectiveness of standard therapies. view more (2007-07-17)
Identifying cancer genes - will it really lead to better treatment?
Copenhagen, Denmark: A systematic trawl through the human genome looking for the abnormalities that drive cancer is already producing promising results, a scientist told ECCO 12 - The European Cancer Conference in Copenhagen today (Tuesday 23 September). Dr. Michael Stratton, Director of the Cancer Genome Project at the Wellcome Trust Sanger... view more... (2003-09-21)
Breast cancer follow-ups "no longer guess-work" thanks to new physics research
As the number of breast cancer patients rises, and hospitals struggle to meet the growing cost of healthcare provision, new research by physicists could help divert funds into frontline treatment such as chemotherapy drugs and better imaging technology. Breast cancer is the most common form of cancer in England and Wales and one in nine women... view more... (2004-02-25)
Genomic signatures identify targeted therapies for lung cancer
Any number of things can go wrong in the cells of the body to cause cancer -- and clinicians can't tell by just looking at a tumor what exactly triggered the once normal cells to turn cancerous. view more (2007-06-04)
UCL study shows beans beat cancer
Scientists have discovered a new and potent anti-cancer compound in everyday food. The collaborative study led by UCL (University College London) shows that the compound-inositol pentakisphosphate-found in beans, nuts and cereals inhibits a key enzyme (phosphoinositide 3-kinase) involved in tumour growth. view more (2005-09-16)
Blood pressure drugs could help halt pancreatic cancer spread, Jefferson researchers find
Common blood pressure medications might help block the spread of pancreatic cancer, researchers at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have found. view more (2006-12-08)
Queensland researchers get the latest tools to fight cancer
University of Queensland researchers will be at the forefront of fighting cancer thanks to a new $3.2 million grant from the Australian Cancer Research Foundation (ACRF). view more (2008-03-20)
Cholesterol-lowering drugs not associated with increased breast cancer risk
A report being published in the Journal of the National Cancer Institute found that women who took statins-the widely used cholesterol lowering drugs-do not face an increased breast cancer risk as had been suggested by some previous studies. view more (2006-05-17)
Chemotherapy after surgery extends survival for patients with advanced endometrial cancer
A new study has shown for the first time that giving two chemotherapy drugs to women with advanced endometrial cancer after surgery reduced the risk of recurrence by 29% and extended survival by 32% compared with women who received whole abdominal irradiation. view more (2005-12-06)
Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy
A team of researchers led by Fred Hutchinson Cancer Research Center has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin. They describe their research online Feb. 10 in the journal Nature. view more (2008-02-11)
U-M researchers link pathway to breast cancer stem cells
A gene well known to stop or suppress cancer plays a role in cancer stem cells, according to a new study from the University of Michigan Comprehensive Cancer Center. The researchers found that several pathways linked to the gene, called PTEN, also affected the growth of breast cancer stem cells. view more (2009-06-02)
Canadian research breakthrough holds promise for development of effective cancer therapies
Researchers Dr. Marc Therrien at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, and Dr. Frank Sicheri, at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto, have discovered a new target that may be instrumental in the development of new, more effective cancer... view more... (2009-09-03)
Diet and lifestyle critical to recovery, says study
Diet and lifestyle may play a much more significant role in a person's ability to respond favourably to certain drugs, including some cancer therapies, than previously understood, say scientists. view more (2008-01-18)
|
|
| Page
5 of
135 |
2691 Results |
|
|
|
Sort By:
Page Views | Date |
|
